New COVID-19 Vaccine to Seek Emergency Use Authorization from FDA
Dimensions of Dental Hygiene
FEBRUARY 23, 2022
Sanofi and GSK are expected to request Emergency Use Authorization from the United States Food and Drug Administration (FDA) for its two-dose COVID-19 vaccine that uses traditional immunization technology rather than the new mRNA approach implemented by the Pfizer and Moderna COVID-19 shots.
98 
Let's personalize your content